Edmond De Rothschild Holding S.A. Charles River Laboratories International, Inc. Transaction History

Edmond De Rothschild Holding S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$183.71 - $210.25 $219,349 - $251,038	-1,194 Reduced 13.97%	7,355 $1.55 Million
Q1 2023 May 11, 2023	BUY	$191.89 - $259.92 $223,935 - $303,326	1,167 Added 15.81%	8,549 $1.73 Million
Q4 2022 Feb 09, 2023	SELL	$197.11 - $250.07 $30,946 - $39,260	-157 Reduced 2.08%	7,382 $1.61 Million
Q3 2022 Nov 09, 2022	BUY	$182.44 - $250.54 $1.38 Million - $1.89 Million	7,539 New	7,539 $1.48 Million

696

51.8M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.33B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.